Evaluating Use of New AI Technology in Diagnosing COVID-19

Published in the Journal of the American Medical Informatics Association, University of Minnesota researchers led a study evaluating federated learning variations for COVID-19 diagnosis in chest x-rays. Federated learning is an artificial intelligence (AI) technique that enables multiple parties to develop and train AI models collaboratively without the need to exchange or centralize data sets.

This research is a collaboration between the U of M, M Health Fairview, Emory University, Indiana University School of Medicine and University of Florida.

The research team compared the performance of a single site to a three-client federated model using a previously described COVID-19 diagnostic model. They found personalized federated learning may offer an opportunity to develop both internal and externally validated algorithms.

"Federated learning is an important future solution for AI in healthcare," Christopher Tignanelli, MD, MS, an associate professor at the University of Minnesota Medical School. "As all machine learning methods benefit greatly from the ability to access data that provides closer to a true global distribution, federated learning is a promising approach to obtain powerful, accurate, safe, robust and unbiased models."

Dr. Tignanelli co-led this study with Ju Sun, PhD, an assistant professor in the College of Science and Engineering. Both are leaders of the Program for Clinical AI in the Center for Learning Health System Sciences at the U of M Medical School.

"We're proud to be among the first teams implementing and further refining federated learning in real-world healthcare settings, with the strong support of industrial partners including Nvidia and Cisco," said Sun. "Data is the oil for modern AI, and federated learning makes the perfect oil refinery to advance AI for healthcare."

By enabling multiple parties to train collaboratively without the need to exchange or centralize data sets, the research team says federated learning helps protect sensitive medical data and may open new research and business avenues to improve patient care.

State-of-the-art algorithms are usually evaluated on carefully curated data sets originating from only a few sources, rather than truly representative data. This can introduce biases where demographics or technical imbalances skew predictions and adversely affect the accuracy for certain groups or sites. Researchers say to capture subtle relationships between disease patterns, socio-economic and genetic factors, and complex and rare cases, it is crucial to expose a model to diverse cases.

The research team says other potential benefits of federated learning include:

  • Improved medical image and text analysis;
  • Better diagnostic tools for clinicians;
  • Collaborative and accelerated drug discovery;
  • Decreased cost and time-to-market for pharmaceutical companies;
  • Rare disease cases where no single institution has enough cases to train models.

"We truly believe the potential impact on precision medicine and ultimately improving medical care is very promising," said Dr. Tignanelli.

Further research is suggested to address more technical questions in using this technology. Part of the funding for this research was provided by Cisco.

Le Peng, Gaoxiang Luo, Andrew Walker, Zachary Zaiman, Emma K Jones, Hemant Gupta, Kristopher Kersten, John L Burns, Christopher A Harle, Tanja Magoc, Benjamin Shickel, Scott D Steenburg, Tyler Loftus, Genevieve B Melton, Judy Wawira Gichoya, Ju Sun, Christopher J Tignanelli.
Evaluation of federated learning variations for COVID-19 diagnosis using chest radiographs from 42 US and European hospitals.
Journal of the American Medical Informatics Association, 2022. doi: 10.1093/jamia/ocac188

Most Popular Now

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

A Blood Test for Cancer Shows Promise Th…

A team of researchers at the University of Wisconsin­-Madison has successfully combined genomics with machine learning in the quest to develop accessible tests that allow earlier detection of cancer. For many...

Open Call HORIZON-HLTH-2023-STAYHLTH-01:…

This topic aims at supporting activities that are enabling or contributing to one or several impacts of destination 1 "Staying healthy in a rapidly changing society". To that end, proposals...

Biomedical Institutions Agree on a Set o…

Eighty stakeholders from twenty major biomedical research institutions across the globe have agreed upon a list of 19 open science practices to be implemented and monitored. The study, led by...